U.S. market Open. Closes in 3 hours 41 minutes

NVIV | InVivo Therapeutics Holdings Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312010-03-312009-03-312008-03-312007-03-312006-03-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue445.00K372.00K329.00K322.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-445.00K-372.00K-329.00K-322.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses10.65M9.90M9.10M11.50M12.77M24.59M24.06M22.40M17.84M19.01M12.78M8.66M3.40M56.06K64.51K35.65K452.00K34.14K
Selling, General & Admin5.42M5.52M5.16M5.89M7.84MN/AN/AN/AN/AN/AN/AN/A1.72M56.06KN/AN/A450.96K34.14K
Research & Development5.23M4.38M3.94M5.60M4.93M11.08M12.56M10.06M10.27M10.53M6.38M4.10M1.67MN/AN/AN/AN/AN/A
Other Operating Expenses9.00K2.00K4.00K79.00K1.30M13.51M11.51M12.34M7.57M8.47M6.40M4.56MN/AN/A64.51K35.65K1.04KN/A
Operating Income-10.65M-9.90M-9.10M-11.50M-12.77M-24.59M-24.06M-22.40M-17.84M-19.01M-12.78M-8.66M-3.40M-56.06K-64.51K-35.65K-452.00K-34.14K
Other Expenses / Income160.00K5.00K23.00K-333.00K-10.66M-2.15M625.00K-10.92M-507.00K-19.75M17.44M-26.07M-5.10MN/AN/A6.001.55K-885.00
Before Tax Income-10.49M-9.89M-9.07M-11.83M-23.42M-26.75M-23.44M-33.31M-18.35M-38.76M4.66MN/AN/AN/A-64.51K-35.64K-450.45K-35.03K
Income Tax Expenses-311.00K-3.00K-19.00K412.00K22.82MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-10.18M-9.89M-9.05M-12.24M-46.24M-26.75M-23.44M-33.31M-18.35M-38.76M4.66M-34.73M-9.06M-61.97K-64.51K-35.64K-450.45K-35.03K
Interest Expenses151.00KN/A19.00K254.00K206.00K74.00K155.00K172.00K136.00K129.90K71.73K12.68K564.44K5.91KN/AN/A573.00885.00
Basic Shares Outstanding1.54M1.32M276.11K13.41K6.65K1.76K41.37K35.28K29.44K24.66K21.07K17.30K11.12K3.74K3.74K3.74K1.61K3.74K
Diluted Shares Outstanding1.54M1.32M276.11K13.41K6.65K1.76K41.37K35.28K29.44K24.66K23.97K17.30K11.12K3.74K3.74K3.74K1.61K3.74K
EBITDA-10.21M-9.53M-8.77M-10.51M-511.00K-26.28M-23.51M-21.71M-17.09M-18.26M-12.41M-8.51M1.75M-56.06K-64.51K-35.64K-449.88K-34.14K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-10.34M-9.89M-9.05M-11.58M-23.22M-26.67M-23.28M-33.14M-18.21M-38.63M4.74M-34.72M-8.49M-56.06K-64.51K-35.64K-449.88K-34.14K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312010-03-312009-03-312008-03-312007-03-312006-03-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙